Sep 2, 2008

Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours

Jul 14, 2008

Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)

Jun 20, 2008

Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Jun 12, 2008

Oncolytics Biotech Inc. to Present at BIO 2008 International Convention

Jun 10, 2008

Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)

Jun 5, 2008

Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Jun 2, 2008

Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting

May 30, 2008

Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting

May 23, 2008

Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent

May 22, 2008

Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)